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Naked mole rat (MR) Heterocephalus glaber is a rodent model
of delayed aging because of its unusually long life span (>28
years). It is also not known to develop cancer. In the current
work, tissue imaging by x-ray fluorescence microscopy and
direct analyses of trace elements revealed low levels of selenium
in the MR liver and kidney, whereas MR and mouse brains had
similar selenium levels. This effect was not explained by uniform
selenium deficiency because methionine sulfoxide reductase
activities were similar in mice and MR. However, glutathione
peroxidase activity was an order of magnitude lower in MR liver
and kidney than in mouse tissues. In addition, metabolic labeling
of MR cells with 75Se revealed a loss of the abundant glutathione
peroxidase 1 (GPx1) band, whereas other selenoproteins were preserved. To characterize the MR selenoproteome, we sequenced its
liver transcriptome. Gene reconstruction revealed standard selenoprotein sequences except for GPx1, which had an early stop
codon, and SelP, which had low selenocysteine content. When
expressed in HEK 293 cells, MR GPx1 was present in low levels, and
its expression could be rescued neither by removing the early stop
codon nor by replacing its SECIS element. In addition, GPx1
mRNA was present in lower levels in MR liver than in mouse liver.
To determine if GPx1 deficiency could account for the reduced
selenium content, we analyzed GPx1 knock-out mice and found
reduced selenium levels in their livers and kidneys. Thus, MR is
characterized by the reduced utilization of selenium due to a specific defect in GPx1 expression.

Naked mole rat (MR)2 (Heterocephalus glaber) is a unique
organism in the mammalian order rodentia. It is an attractive
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model to study aging due to an extraordinary life span (more
than 28 years), which is unprecedented for rodents of similar
body size. Aging in MRs is characterized by very slow age-related declines that do not significantly affect breeding capacity,
social behavior, and daily activity (1–3). MR evolved a unique
eusocial lifestyle with strictly determined social roles and cooperative breeding within the colony. The anatomy of MR has
several specific features, which probably evolved as an adaptation to living underground in oxygen-limiting conditions,
including underdevelopment of the visual system (4), skin
insensitivity (5), and the ability to tolerate low temperature (6)
and low oxygen levels (7). MRs are also characterized by a
decreased metabolic rate, which is associated with reduced levels of thyroid hormones (3). One of the most remarkable features of MR is that none of the autopsies of dead animals in
several colonies revealed cancer incidence (1). Moreover, primary fibroblasts derived from MR were sensitive to contact
inhibition (8), resistant to experimentally induced tumorigenesis, and unable to form xenograft tumors (9).
MR poses a challenge to the theories that link aging, cancer,
and oxidative stress. Because MR lives in low oxygen conditions, it is expected to have low levels of oxidative stress. However, research showed that MR is characterized by significant
oxidative damage. Compared with mice, MRs have a lower
GSH/GSSG ratio, higher rate of lipid peroxidation, higher rate
of DNA oxidative damage, and higher protein carbonylation
(10). It was also demonstrated that MR proteins possess higher
levels of protein thiols, increased protein stability, increased
resistance to urea-induced denaturation, and elevated proteasomal activity while also showing lower levels of protein ubiquitination. Moreover, unlike the mouse proteome, the MR proteome did not show significant age-related susceptibility to
oxidation and ubiquitination (11). A separate study did not
detect age-related changes in the activities of antioxidant
enzymes, including Mn-superoxide dismutase, Cu/Zn-super-

MsrA, methionine-S-sulfoxide reductase; MsrB, methionine-R-sulfoxide
reductase; Sec, selenocysteine; SECIS, selenocysteine insertion sequence;
SelP, selenoprotein P; XFM, x-ray fluorescence microscopy; contig, group
of overlapping clones; EGFP, enhanced green fluorescent protein; BisTris,
2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol.

JOURNAL OF BIOLOGICAL CHEMISTRY

17005

Reduced Selenium Utilization by Naked Mole Rats
oxide dismutase, and catalase, and also observed low glutathione peroxidase (GPx) activity (12).
Mammals have eight GPxs, including five selenoproteins.
GPx1 is the first identified and one of the best studied selenoproteins (13). This and other selenoprotein GPxs have selenocysteine (Sec) residues in their active sites. GPx1 is a cytosolic
enzyme and the most abundant selenoprotein in mammals.
Other GPxs show different cellular localizations and/or tissue
and substrate specificities (14, 15). GPx1 is not an essential
enzyme (i.e. GPx1 knock-out mice are viable and fertile). However, GPx1 knock-out mice are more susceptible to oxidative
stress (16, 17) and viral myocardites (18). Expression of GPx1 is
decreased in prostate cancer and breast cancer cell lines (19) as
well as in the mouse model of liver cancer (20). A single nucleotide polymorphism that changes Pro to Leu at codon 198 of
human GPx1 is associated with lung (21) and bladder (22)
cancers.
Currently, there is no information on the utilization of selenium by MR; however, this is an essential trace element in
mammals, and its supplementation may be beneficial in cancer
chemoprevention (23). Selenium functions mostly through
incorporation into proteins in the form of Sec. Mice and
humans have 24 and 25 selenoprotein genes, respectively (24).
However, nothing is known about the composition of the MR
selenoproteome.
In this study, we observed low levels of selenium in MR tissues. This observation led to the finding that the reduced utilization of selenium by this organism was due to a specific defect
in GPx1 expression.

EXPERIMENTAL PROCEDURES
Animals—Animal experiments were approved by institutional animal care and use committees at the University of Illinois (Chicago, IL) and University of Nebraska (Lincoln, NE). To
carry out inductively coupled plasma mass spectrometry (ICPMS) analyses, Western blotting, activity assays, and other analyses, animals were sacrificed, and their tissues were frozen in
liquid nitrogen and stored until use. To prepare extracts, tissues
were homogenized in PBS supplemented with a protease inhibitor mixture (Sigma). Cellular debris was removed by centrifugation at 13,000 rpm for 15 min at 4 °C, and protein concentrations were determined by the Bradford assay.
Tissue Samples for X-ray Fluorescence Microscopy (XFM)—
Tissues from C57BL/6 mice and MRs were extracted and prepared at the same time to match preparation conditions. Mice
were fed a standard rodent chow diet. MRs were fed either a
sweet potato or carrot diet. Tissues from a 1-year-old MR were
compared with the corresponding samples of a 2-month-old
mouse to adjust for life span differences. All freshly extracted
tissues were washed in PBS and placed in 4% neutral buffered
formaldehyde in PBS for fixation. After 12 h, tissues were transferred to PBS, paraffin-embedded, and cut using a standard
microtome into 5-m sections. Sections were mounted on silicon
nitride windows (2 ⫻ 2 mm, 200-nm thickness; Silson, Blisworth,
UK). Light microscopy images were taken using a Leica DMXR
microscope (Leica Microsystems, Bannockburn, IL).
XFM—Trace elements in mouse and MR tissue samples were
imaged with XFM at the Advanced Photon Source, Argonne
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National Laboratory (Argonne, IL). For each pixel, the full x-ray
fluorescence spectrum was recorded using a single-element silicon drift detector (Vortex EX, SII Nanotechnology,
Northridge, CA). Dwell time varied from 1.1 to 4 s/pixel. For
quantification, each set of experiments was followed by recording x-ray fluorescence spectra of thin film standards NBS-1832
and NBS-1833 (National Bureau of Standards). X-ray fluorescence spectra for each sample were fitted and quantified using
data derived from standards. Image processing and analysis
were performed using MAPS software (25). Each x-ray fluorescence image represents two-dimensional distribution of the
element.
Activity Assays—Total GPx activity was measured using a
GPx activity kit (Sigma) according to the manufacturer’s
instructions. Methionine-S-sulfoxide reductase (MsrA) and
methionine-R-sulfoxide (MsrB) activities were measured in an
HPLC assay as described (26). Briefly, 200 g of total protein
were added to a reaction mixture that was kept at 37 °C for 30
min in the presence of 20 mM DTT and either 200 M dabsylmethionine-S-sulfoxide (to assay for MsrA activity) or 200 M
dabsyl-methionine-R-sulfoxide (to assay for MsrB activity).
After stopping the reaction by adding 200 l of acetonitrile, it
was centrifuged at 4 °C for 15 min at 13,000 rpm, and the supernatant (50 l) was injected onto a C18 column (ZORBAX
Eclipse XDB-C18) to quantify the resulting dabsylated
methionine.
Splenocyte Isolation and 75Se Metabolic Labeling—After dissection, spleen was immediately transferred into ice-cold
DMEM and mashed through a 45-m cell strainer into the
50-ml tube. Cells were centrifuged at 800 ⫻ g for 5 min. The
pellet was resuspended in 5 ml of ASK buffer (Invitrogen) and
incubated at room temperature for 5 min. Cells were then
diluted with DMEM and pelleted at 800 rpm for 5 min. The
resulting pellet was resuspended in 15 ml of DMEM supplemented with 10% fetal bovine serum (Invitrogen), antibiotic/
antimicotic (Invitrogen), 0.4 mM glutamine, and freshly neutralized 75Se selenious acid (specific activity 1000 Ci/mmol,
final concentration in the medium 1 nM) and pooled into a
15-cm plate. After 24 h, cells were washed three times with
ice-cold PBS and lysed in CellLytic buffer (Sigma). Protein
extracts were analyzed by SDS-PAGE followed by
autoradiography.
Whole Transcriptome Sequencing and Assembly of Selenoprotein Genes—Extraction of the total RNA from MR liver was
carried out using an RNAqueous kit (Ambion) according to the
manufacturer’s instructions. DNA was removed by treatment
with DNase I (Ambion). Liver transcriptome was sequenced at
the University of Nebraska-Lincoln genomic facility on an Illumina instrument. To assemble 35-bp reads into longer contigs,
three different strategies were used. First, mapping of reads to
reference sequence from mouse or guinea pig genomes was
performed using the MAQ package 0.7.1 (available from the
Sourceforge Web site). Second, SOAP package 1.03 (available
from the Short Oligonucleotide Analysis Package Web site) was
used for de novo assembly of short reads. Finally, we employed
an in-house program that was optimized for assembling selenoprotein genes and utilized the variety of information available
VOLUME 286 • NUMBER 19 • MAY 13, 2011
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from MAQ and SOAP output as well as known sequences from
other rodents.
ICP-MS—Quantitative analyses of trace elements in animal
tissues were performed using ICP-MS. Freshly frozen mouse
and MR tissues were homogenized and sonicated in PBS with
Complete protease inhibitor mixture (Roche Applied Science)
(1 tablet in 50 ml of PBS). Samples were normalized to protein
content in each lysate, as determined using the Bradford Protein Kit (Bio-Rad). Samples were digested in 15% nitric acid,
15% hydrogen peroxide for 2 h at 70 °C. 50 ppb gallium were
added as an internal control to the digestion mix. After digestion, samples were diluted 10 times with deionized water and
analyzed by ICP-MS. Elemental analysis was performed at the
University of Nebraska-Lincoln Spectroscopy Core Facility
using an Agilent Technologies ICP-MS model 7500ce (Santa
Clara, CA) and an Elemental Scientific Inc. (Omaha, NE) SC4
autosampler. Each sample was analyzed in triplicate. The carrier and make-up gas flows were 0.95 and 0.15 liter/min of
argon, respectively. The collision cell operated with 3.5 ml/min
H2 and 1.5 ml/min helium for reaction/collision mode. Dwell
times for all elements were 0.3 s except 78Se, for which the dwell
time was set at 0.9 s. Gallium (m/z ⫽ 71) was added to all samples and standards as an internal standard at 50 ppb.
Expression Constructs for Mouse and MR GPx1 and Their
Mutants—Mouse and MR GPx1 cDNAs containing the
3⬘-UTRs, including SECIS elements, were amplified by a twostep PCR with primers that introduced Myc tag into ORFs.
Primers were designed as follows: mouse first round (CTCAGAGGAGGATCTCTGTGCTGCTCGGCTCTCCG and GCATACTCTAGACTGATATTCAGCACTTTATTCTTAGTAGTGAAACC) and second round (CTCAGAGGAGGATCTCTGTGCTGGTCGTTTGGCCGCGGCC and GCATACTCTAGACTGATATTCAGCACTTTATTCTTAGTAGTGAAACC); MR first round (CTCAGAGGAGGATCTCTGTGCTGGTCGTTTGGCCGCGGCC and GCATACTCTAGAACACCCAGCACTTTATTAGAGGGTAATCATTTTGG) and
second round (GCATACTCTAGAACACCCAGCACTTTATTAGAGGGTAATCATTTTGG and ATGACATCTCGAGATGGAGCAGAAGCTCATCTCAGAGGAGGATCTC). The
PCR products were digested with XhoI and Xba and ligated into
a similarly digested pCIneo vector. In the case of mouse GPx1,
an early premature stop codon was introduced using site-directed mutagenesis with the QuikChange kit (Stratagene) and
primers GAAACCCTGCTGTCCTAGCAGTCTGGCAAC and
GTTGCCAGACTGCTAGGACAGCAGGGTTTC. The resulting mutant was designated as the M-short form. To rescue the
early stop codon in MR GPx1, we performed site-directed
mutagenesis with primers AAGCCCTACTCACTCAGGGGCGCGGCCCTG and CAGGGCCGCGCCCCTGAGTGAGTAGGGCTT, and the resulting mutant was designated as the
MR-long form. To obtain cysteine mutants of mouse and MR
GPx1, we used site-directed mutagenesis with primers TCGCGTCTCTCTGCGGCACCACGAT and ATCGTGGTGCCGCAGAGAGACGCGA for mouse GPx1 and GAATGTGGCATCCCTCTGCGGCACCACGGTC and GACCGTGGTGCCGCAGAGGGATGCCACATTC for MR GPx1. To obtain a
pBudGE/GFP construct, EGFP was amplified from pEGPFN3
vector with primers ATGACAAGCTTATGGTGAGCAAGGMAY 13, 2011 • VOLUME 286 • NUMBER 19

GCGAGG and GGACATTCTAGATTACTTGTACAGCTCGTCC. The resulting PCR product was ligated into a similarly
digested pBudCE4.1 vector. Mouse and MR GPx1 mutants
were amplified from pCIneo constructs with primers GGTACCATGGAGCAGAAGCTCATCTCAGAGG/GCATACGCATACAGATCTCTGATATTCAGCACTTTATTCTTAG and
GGTACCATGGAGCAGAAGCTCATCTCAGAGG/AGATCTACACCCAGCACTTTATTAGAGG, respectively, and
inserted into the second multiple cloning site of the
pBudCE4.1/GFP vector at Bglll/Kpnl restriction sites. Cys
mutants were amplified with GGTACCATGGAGCAGAAGCTCATCTCAGAGG and GCATACAGATCTTTAGGAGTTGCCAGACTGC (mouse) and GGTACCATGGAGCAGAAGCTCATCTCAGAGG and GCATACAGATCTCTATGCAGGGCCGCGCCCC (MR) and inserted into the vector without
the 3⬘-UTR. To express mouse and MR GPx1 mutants in a bacterial expression system, GPx1 mutants were amplified with
primers ATGCATCATATGGAGCAGAAGCTCATCTCAGAGG and GCATGCTCGAGTTAGGAGTTGCCAGACTGC (mouse) and ATGCATCATATGTGTGCTGGTCGTTTGGCCG and GCATGCTCGAGCTATGCAGGGCCGCGCCCC (MR) and cloned into pET28a expression vector at NdeI
and XhoI sites.
To clone mouse and MR GPx1 into pSelExpress1, mouse and
MR GPx1 coding sequences were amplified with ATGACATAAGCTTATGGAGCAGAAGCTCATCTCAGAGG and
GCATACTCTAGATTAGGAGTTGCCAGACTGC (mouse)
and ATGACATAAGCTTATGGAGCAGAAGCTCATCTCAGAGG and GCATACTCTAGACTATGCAGGGCCGCGCCCC (MR) primers, digested with HindIII and XbaI restriction endonucleases, and ligated into pSelExpress1 vector. To
swap mouse and MR 3⬘-UTRs, we prepared the corresponding
constructs on the basis of the pBudCE4.1/GFP vector, which
expressed Myc-tagged GPx1 and GFP from separate sites in the
construct.
Cell Culture, Transfections, Metabolic Labeling, Immunoprecipitation, and Western Blot Analyses—HEK 293 and HeLa
cells were cultured in DMEM supplemented with 10% FBS, 100
units/ml penicillin, and 100 units/ml streptomycin. All transfections were performed with Lipofectamine transfection reagent (Invitrogen), according to the manufacturer’s manual.
Eighteen hours after transfection, medium was replaced with
one containing freshly neutralized 75Se selenious acid (specific
activity 1000 Ci/mmol, final concentration in the medium 1
nM). Cells were labeled for 24 h, and cellular extracts were analyzed by SDS-PAGE followed by autoradiography. For immunoprecipitation, HEK 293 cells were grown on 10-cm plates,
transfected with various GPx1 constructs, and metabolically
labeled with 75Se. Cells were resuspended in PBS, supplemented with protease inhibitor mixture (Sigma), and treated
with a tissue homogenizer. 600 g of total protein were subjected to immunoprecipitation with the Protein G immunoprecipitation kit with mouse anti-Myc antibodies (Invitrogen),
according to the manufacturer’s instructions. For Western blot
analyses, samples were separated on 10% BisTris gels, transferred onto PVDF membranes, and incubated with mouse antiMyc (Invitrogen) or anti-GFP (Sigma) antibodies.
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 1. XFM and ICP-MS analysis of selenium in mouse and MR tissues. Shown are XFM scans of mouse and MR livers (A) and testes (B). Each element and
its maximum and minimum threshold values are given above each image in ng/cm2. The rainbow-colored scale bar relates to the signal intensity measured as
ng/cm2 in each spot, with dark pixels representing areas of low concentration and a gradient to bright pixels depicting increasing concentrations. A scale bar is
shown below the elemental maps. C, selenium was analyzed by ICP-MS in mouse and MR tissues. Values are means ⫾ S.D. (error bars). Organs in which trace
elements were analyzed are shown below each panel.

RNA Isolation and Quantitative PCR—To compare GPx1
expression levels in mice and MRs, total liver RNA was isolated
by TRIzol extraction according to the manufacturer’s instructions. Genomic DNA was removed using a DNA removal kit
(Ambion). RNA concentration was measured spectrophotometrically, and cDNA was obtained with Superscript III reverse
transcriptase (Invitrogen) using the oligo(dT) primer. Realtime PCR was performed using a Fast SYBR Green master mix
(Applied Biosystems). Primer sequences for the GPx1 expression analysis were as follows: mouse, CAGGAGAATGGCAAGAATGAAG and GAAGGTAAAGAGCGGGTGAG; MR,
GACACCAGGAAAACGCAAAG and AAGGTGAAGAGCGGATGTG (primers were based on the assembled transcriptome sequences). GPx1 expression was normalized to that of
aldolase. Primers for aldolase expression were as follows:
mouse, GTGATCCTTTTCTACGAGACCC and ACCACAATTCCCTTCTCCTTG; MR, AAGATGGGTGTGACTTTGGG and GGTACTAGCCCATTCTGTTGAC.
Additional Analyses of mRNAs—RNA was isolated from cells
transfected with various GPx1 constructs inserted into
pBudCE/GFP vector. It was then treated with RNase-free
DNase I (Fermentas). The resulting RNA samples were reverse
transcribed with a SuperScript VILO cDNA synthesis kit (Invitrogen). Quantitative PCR was performed using a Fast SYBR
Green Master Mix (Applied Biosystems). To distinguish
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recombinant GPx1 from the endogenous form, we used the
direct primer specific for Myc-tag (TCATCTCAGAGGAGGATCTC) and reverse primers as follows: TGAGCCTTCTCACCATTCACTTCG (mouse) and CGAGCACTACCAGGCCTCTGG (MR). Expression of GPx1 mutants was
normalized to EGFP expressed from the same vector. Primers
for EGFP were as follows: TCAAGGACGACGGCAACTAC
and TTGTGCCCCAGGATGTTGCC.
Protein Isolation and Activity Assays—Recombinant cysteine
GPx1 mutants were expressed in BL21(DE3) cells (Novagen).
E. coli cells were transformed with various GPx1 constructs,
and the cells were grown until an OD of 0.6 at 600 nm. Protein
expression was induced overnight with 1 mM isopropyl 1-thio␤-D-galactopyranoside. Cells were harvested by centrifugation,
homogenized in 50 ml of PBS supplemented with Protease
Inhibitor Mixture EDTA-free (Roche Applied Science), and
sonicated on ice for 20 min. The suspension was centrifuged at
9000 rpm, and the resulting lysates were assayed for protein concentration and fractionated on a TALONTM column (Clontech).
Fractions containing GPx1 mutants were dialyzed against PBS and
subjected to activity assays using a GPx kit (Sigma).

RESULTS
Low Levels of Selenium in MR Tissues—We analyzed the levels and distribution of selenium in various tissues of MR,
VOLUME 286 • NUMBER 19 • MAY 13, 2011
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H. glaber. Mouse tissues were used for comparison because
mice are rodents of similar size. Paraffin-embedded tissue sections were first imaged using synchrotron XFM. Selenium was
uniformly distributed in liver (Fig. 1A), heart, and lung tissues
in both organisms. Mouse testes are known to accumulate selenium in elongating spermatids (28). However, such selenium
enrichment was not observed in MR testes (Fig. 1B). We estimated selenium content in specific areas of MR and mouse
tissues (supplemental Fig. S1). Most MR tissues had considerably lower selenium levels (30 –75% lower). However, MR and
mouse brain samples had similar selenium contents. The brain
is known to retain selenium during deficiency (29).
To verify the XFM observation of low selenium in MR tissues, we measured selenium in MR and mouse tissues using
ICP-MS. All MR tissues analyzed, except the brain, had lower
selenium levels than the corresponding mouse tissues (Fig. 1C).
The major selenium pool in mice is in the liver; however, MR
liver had low amounts of selenium. Thus, MR is characterized
by apparent selenium deficiency.
Low GPx Activity in MR Tissues—Because selenium mostly
occurs in the form of Sec in proteins, the low selenium in MR
tissues suggested a decreased expression of selenoproteins. To
test this hypothesis, we assayed methionine sulfoxide reductase
and GPx activities. Mammals have three MsrBs, including the
selenoprotein MsrB1, which is the major MsrB in mouse liver
(30). Because it is responsible for MsrB activity in the cytosol
and nucleus (MsrB2 and MsrB3 are mitochondrial and endoplasmic reticulum proteins, respectively), it is probably the
main MsrB in all mammals. MsrB1 expression and activity (as
well as total MsrB activity) depend on dietary selenium. Mammals also have a single MsrA, which is not a selenoprotein. We
found that both MsrA and MsrB activities were similar in mice
and MRs (Fig. 2, A and B). Thus, low selenium in MR tissues
cannot be explained by uniform selenoprotein deficiency.
GPx1 is a major mammalian GPx, which is, like MsrB1, easily
regulated by dietary selenium. We found extremely low GPx
activity in MR liver compared with the corresponding mouse
tissue (Fig. 2C). Low selenium in the liver correlated with low
GPx activity, which was suggestive of low GPx1 expression.
Sequencing and Analysis of the MR Liver Transcriptome—
Several rodent genomes were sequenced in recent years, but the
genome of MR is not available. To characterize selenoprotein
occurrence in MRs, we performed sequencing of the MR liver
transcriptome using Illumina technology. Overall, 25,011,515
36-bp-long reads were obtained and assembled into contigs. The
length distribution of assembled contigs is shown in Fig. 3A. The
best results were obtained using k-mer size of 23, wherein 395,038
contigs were generated, with 40,073 contigs longer than 100 bp
and 379 contigs exceeding 1000 bp.
Occurrence of selenoprotein genes was then examined, and
we detected 15 selenoprotein sequences. This analysis suggested that the MR selenoproteome is similar to that of other
mammals. Schematic representation of the human selenoproteome (which contains 25 selenoproteins) is shown in Fig. 3B,
with MR orthologs identified in the current study highlighted.
The lack of some selenoprotein genes was probably due to
insufficient sequencing depth, but it also could be an indicator
of their low expression in MR liver. Overall, although selenium
MAY 13, 2011 • VOLUME 286 • NUMBER 19

FIGURE 2. MR tissue extracts have low GPx1 expression and activity. Total
MsrB (A), MsrA (B), and GPx (C) activities were measured in the indicated
mouse and MR tissues. D, primary splenocytes derived from MR and mice
were metabolically labeled with 75Se, and protein extracts were analyzed by
SDS-PAGE followed by autoradiography. The band corresponding to GPx1 is
shown with an arrow on the right. E, relative expression of GPx1 mRNA in MR
and mouse liver (*, p ⬍ 0.05). Error bars, S.D.

levels and GPx activity were low in MR liver, this organ
expressed many selenoprotein mRNAs, and the majority of
these sequences had no unusual features (supplemental Figs.
S2–S16).
SelP is the only mammalian selenoprotein that contains
more than one Sec, and it has two SECIS elements in the
3⬘-UTR. Mammalian SelPs generally have 10 –15 Sec residues
(e.g. 10 Sec residues in human, mouse, and rat SelPs) (31). However, we found only 7 Sec residues in MR SelP (supplemental
Fig. S2). Together with SelP from Cavia porcellus, this is the
lowest Sec content of any vertebrate SelP.
In addition, we detected an unusual feature in MR GPx1: an
early stop codon present five codons upstream of the position
terminating GPx1 synthesis in other mammals (Fig. 3C and
supplemental Fig. S3). Thus, MR GPx1 was predicted to be 5
amino acids shorter than other mammalian GPx1s. SECIS elements in MR selenoprotein genes satisfied the requirements of
a canonical eukaryotic SECIS model. Overall, it is likely that the
MR selenoproteome is not significantly different from that of
other mammals, with the exception of SelP and GPx1
sequences.
Low GPx1 Expression in MR—To test for GPx1 expression
levels, we isolated mouse and MR splenocytes and metaboliJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. Transcriptome analysis and characterization of the MR selenoproteome. A, length distribution of assembled contigs of the MR liver transcriptome. B, selenoproteins identified in MR. The human selenoproteome is used as a reference to represent the MR selenoproteome. Selenoproteins identified by
sequencing the MR liver transcriptome are highlighted. The location of Sec residues is indicated by a red line. Seven Sec residues were found in SelP. GPx1 has
an early termination codon (see “Results”). C, schematic representation of MR GPx1 in comparison with mouse GPx1.

cally labeled the cells with 75Se, and they were analyzed by SDSPAGE followed by autoradiography (Fig. 2D). It appeared that
the GPx1 band was missing in MR splenocytes. To test if low
GPx1 expression and activity were due to a low mRNA expression, GPx1 mRNA levels were examined by real-time PCR. We
found that the MR GPx1 mRNA was expressed at much lower
levels than mouse GPx1 mRNA in the liver (Fig. 2E). Thus, the
low GPx1 activity was, at least in part, due to low GPx1 mRNA
levels.
Reduced Expression of MR GPx1 in Transfected Mammalian
Cells—An early stop codon in MR GPx1 could also contribute
to the low expression and activity of GPx1. To test this possibility, we prepared constructs containing MR GPx1 with the
early UAG stop codon and the one where UAG was replaced
with CAG (encoding glutamine present in mouse GPx1 at this
position). As a control, we prepared mouse GPx1 and its
mutant, in which the CAG codon was changed to UAG (Fig.
4A). The constructs were transfected into HEK 293 cells,
which were then labeled with 75Se and analyzed for selenoprotein expression patterns (Fig. 4C, top). The same membrane was also subjected to Western blot analysis with antiMyc antibodies (Fig. 4C). To distinguish exogenous
selenoproteins from the endogenous GPx1, proteins were
immunoprecipitated with anti-Myc antibodies and analyzed
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on a gel (Fig. 4C, bottom). Expression levels of MR GPx1 were
much lower than that of mouse GPx1. Introduction of CAG
in place of UAG further decreased MR GPx1 expression. At
the same time, substitution of CAG with UAG in mouse
GPx1 did not decrease GPx1 expression.
In addition, mouse and MR GPx1 forms were cloned into a
pBudCE4.1 vector, containing GFP under the CMV promoter.
In further experiments, GFP was used as an internal control for
transfection and protein loading. Inhibition of proteasome in
HEK 293 cells did not rescue MR GPx1 expression (Fig. 4D). In
addition, real time PCR analysis revealed no difference between
mouse and MR GPx1 mRNA after transfection (Fig. 4B). Thus,
MR GPx1 expression was suppressed regardless of the early
stop codon. However, substitution of Sec with cysteine partially
rescued expression of MR GPx1 (Fig. 4E). These data suggest
that incorporation of Sec may limit GPx1 synthesis. We also
checked if the early stop codon in MR GPx1 affects peroxidase activity of this enzyme by expressing Cys-containing
His-tagged MR and mouse GPx1s in bacteria. These mouse
and MR GPx1 proteins had similar activities (supplemental
Fig. S17). The data suggest that the early stop codon affects
neither expression nor activity of the enzyme and that the
low expression of MR GPx1 is due to a combination of low
mRNA levels and decreased Sec insertion. These two factors
VOLUME 286 • NUMBER 19 • MAY 13, 2011
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FIGURE 4. GPx1 is poorly expressed in mammalian cells. A, schematic representation of MR and mouse GPx1 mutant constructs. Positions of Sec and
glutamine (CAG) codons, the stop signal (TAG), and the SECIS element in the 3⬘-UTR are shown. B, mRNA levels were assessed by real-time PCR and normalized
to GFP expressed from the same vector. Results are given ⫾ S.D. (error bars). C, MR and mouse Myc-GPx1 constructs were transfected into HEK 293 cells. Cells
were labeled with 75Se, followed by SDS-PAGE and autoradiography (top). Migration of ectopically expressed GPx1 is shown on the left. The same lysates were
probed with anti-Myc and anti-␤-actin antibodies (two bottom panels). Myc-GPx1 mutants were also immunoprecipitated with anti-Myc antibodies, followed
by PhosphorImager analysis of the 75Se-labeled GPx1. D, mouse and MR constructs were transfected into HEK 293 cells followed by treatment of cells with 10
M MG132 for 12 h. Cells were labeled with 75Se, followed by protein analysis by SDS-PAGE and autoradiography (top). The same membrane was stained with
Myc and GFP antibodies. E, expression of mouse and MR cysteine mutants of GPx1 in HEK 293 cells was analyzed by Western blotting. IP, immunoprecipitation;
WB, Western blotting.

may be linked (e.g. inefficient Sec insertion may destabilize
GPx1 mRNA).
SECIS Element in MR GPx1 Is Not Responsible for Low GPx1
Expression—Sec insertion includes recognition of the SECIS
element in the 3⬘-UTR of selenoprotein mRNAs by SBP2 and
subsequent recruitment of additional factors, such as EFSec
and Sec-tRNA[Ser]Sec, which insert Sec in response to the UGA
codon. Efficiency of Sec incorporation may depend on additional features, such as the position of the UGA codon within
the ORF and the type of SECIS element (32–34). Alignment of
GPx1 SECIS elements revealed a nucleotide substitution in the
conserved SBP2 binding site (Fig. 5A). However, comparison of
MR (Fig. 5B) and mouse (Fig. 5C) SECIS elements in GPx1 did
not show unusual features in the MR SECIS element, suggesting that the predicted structure may support Sec incorporation.
To directly test if the MR GPx1 SECIS element is responsible
for the low GPx1 expression, we cloned coding sequences of
mouse and MR GPx1s into pSelExpress1 vector containing a
highly efficient eukaryotic SECIS element (27). Analysis of
MAY 13, 2011 • VOLUME 286 • NUMBER 19

these expression constructs (containing the same SECIS element) by metabolic 75Se labeling of transfected HEK 293 cells
showed that the MR GPx1 was still expressed at a low level
compared with mouse GPx1 (Fig. 5D). To further examine the
role of SECIS elements as well as the entire 3⬘-UTRs in GPx1
expression, we prepared constructs that swapped the 3⬘-UTRs
between mouse and MR GPx1s. These constructs were
expressed in HEK 293 cells, followed by 75Se labeling and Western blot analysis (Fig. 5E). Substitution of the MR GPx1 3⬘-UTR
with that of the mouse did not increase MR GPx1 expression; in
addition, replacement of the mouse GPx1 3⬘-UTR with that of
the MR did not decrease the expression of mouse GPx1. Thus,
neither the SECIS element nor the 3⬘-UTR were responsible for
the reduced MR GPx1 expression. It is an attractive possibility
that the overall GPx1 mRNA structure modulates the rate of
Sec incorporation.
Absence of GPx1 Decreases Selenium Levels in Mice—GPx1 is
the most abundant selenoprotein in mouse liver and kidney.
We tested if removal of this protein could affect selenium levels
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 5. SECIS element does not decrease GPx1 expression level. A, alignment of mammalian GPx1 SECIS elements. Nucleotides critical for the SECIS
function are underlined. B, MR GPx1 SECIS element as predicted by SECISearch. Functional sites are shown in boldface type (24). C, mouse GPx1 SECIS element.
Functional sites are shown in boldface type. D, mouse and MR GPx1 coding sequences were cloned into pSelExpress1 containing an efficient eukaryotic SECIS
element and expressed in HEK 293 cells. Cells were labeled with 75Se, followed by SDS-PAGE, autoradiography, and Western blotting with Myc antibodies.
Coomassie staining is a loading control. E, coding sequences of mouse GPx1 containing the MR GPx1 3⬘-UTR (M-long-MR SECIS) and coding sequence of MR
GPx1 containing mouse GPx1 3⬘-UTR (MR-short-M SECIS) were expressed in HEK 293 cells. Cells were labeled with 75Se, followed by SDS-PAGE, autoradiography,
and Western blotting with Myc and GFP antibodies. WB, Western blot.

in tissues by examining WT and GPx1 knock-out mice. Selenium levels in GPx1 knock-out mice were almost twice as low as
those in WT livers (Fig. 6) (p ⫽ 0.00387) and kidneys (p ⫽
0.0409). However, in tissues characterized by lower GPx1 levels, such as spleen, heart, lung, and brain, selenium levels were
not affected by GPx1 knock-out. Thus, the absence of GPx1
could indeed be responsible for the reduced selenium use by
MRs.
GPx1 Expression in Long Lived Rodents—To examine if the
aberrant expression of MR GPx1 has evolutionary aspects, we
analyzed its levels in primary skin fibroblasts derived from long
lived rodents, including white footed mouse, chipmunk, vole,
single fox squirrel, beaver, and porcupine, and also examined
fibroblasts from another long lived mammal, the little brown
bat (35). Cells were metabolically labeled with 75Se, and proteins were analyzed by SDS-PAGE followed by autoradiography
(supplemental Fig. S18A). HEK 293 cells were used as a positive
control, and mouse embryonic fibroblasts were derived from
GPx1 knock-out mice as a negative control. All analyzed spe-
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FIGURE 6. Reduction in selenium levels in tissues of GPx1 KO mice. Selenium was determined by ICP-MS in tissues from wild type (WT) and GPx1
knock-out (KO) mice. Values are means ⫾ S.D. (error bars). Organs in which
selenium was analyzed are shown below each panel (**, p ⬍ 0.005; *, p ⬍ 0.05).

cies, except for the porcupine, had a strong band corresponding
to GPx1. In the case of the porcupine, we observed a weak 75Se
signal in the GPx1 position and a stronger band that migrated
VOLUME 286 • NUMBER 19 • MAY 13, 2011
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faster than GPx1. Sequence analysis of GPx1 in these rodents
should await the availability of their genome sequences. However, examination of the phylogenetic tree indicated that MR
and porcupine share a common ancestor (supplemental Fig.
S18B), whereas other examined mammals are more distant.
Thus, it appears that the defect in GPx1 expression may not be
limited to MR and may occur in a subset of rodents.

DISCUSSION
GPx1 is an abundant glutathione peroxidase in mammals. It
plays an important role in the protection of cells from oxidative
stress by reducing hydrogen peroxide with glutathione. Surprisingly, we found that GPx1 is essentially absent in MR tissues, whereas other selenoproteins are expressed at normal levels and/or are enzymatically competent. Sequencing and
analysis of the MR liver transcriptome detected GPx1 mRNA,
but it was present at low levels and had an early termination
codon. Further analyses revealed that the low expression was
probably due to a combination of low mRNA levels and
decreased insertion of Sec rather than due to compromised
GPx1 activity caused by premature termination.
It was reported that GPx1 is the most abundant liver selenoprotein. In rat liver, it accounts for 63% of the total selenium
(36). Selenium deficiency induces rapid degradation of GPx1
mRNA (and several other selenoprotein mRNAs), whereas the
expression levels of several additional selenoproteins are preserved under these conditions (37). GPx1 was proposed as a
biomarker of selenium utilization because its activity is very
sensitive to selenium dietary status. It was also suggested that
GPx1 is a “selenium buffer,” wherein this enzyme stores selenium and provides this element for biosynthesis of selenoproteins during selenium deficiency (38). On the other hand, GPx1
knock-out does not affect expression of other selenoproteins
(39, 40). This enzyme is also not essential. GPx1 knock-out
animals are viable; however, they are more susceptible to oxidative stress and show defects in redox signaling (41). These
data correlate with previously reported increases in oxidative
stress parameters in MR, including a low GSH/GSSG ratio, high
rate of DNA oxidative damage, and increased protein carbonylation and lipid peroxidation (10). Moreover, both GPx1 knockout mice and MRs showed abnormal blood glucose regulation
(39, 40). These mice had a normal fasting glucose but reduced
blood insulin levels (41, 42). However, unlike GPx1 knock-out
mice, MR also showed abnormal glucose tolerance (glucose levels remained elevated for prolonged periods of time) and insulin sensitivity (glucose levels immediately decreased upon insulin administration and remained low for prolonged periods of
time) (10, 43). In addition, GPx1 knock-out mice had reduced
islet ␤-cell mass in pancreatic tissue (42), whereas MR had different abundances of the four distinct types of islet cells.
Although the abnormal glucose regulation may be relevant to
MR adaptation to its specific lifestyle, it could be, at least in part,
due to an abnormal GPx1 function.
Selenium levels in animal tissues vary depending on many
factors, including the requirements of the organism for this
trace element and the diet. Numerous studies have reported on
the role of dietary selenium in human health. For example, selenium deficiency may cause endemic cardiomyopathy (Keshan
MAY 13, 2011 • VOLUME 286 • NUMBER 19

disease), liver degeneration observed in rats and pigs, and white
muscle disease in ruminants and turkeys (23, 44). None of the
selenium deficiency-induced pathologies have been reported
for MR. In this regard, it is particularly interesting that MRs
have never been observed to develop cancer (2). We compared
trace element profiles in control and GPx1 knock-out mice and
found a significant decrease of tissue selenium levels in liver and
kidney. Somewhat similar differences in selenium levels were
observed between mouse and MR. GPx1 is the most abundant
selenoprotein, especially in liver and kidney, and the GPx1
knock-out data suggest that this protein accounts for approximately half of selenium in these organs.
We also observed significant differences in selenium in
spleen, lungs, and testes (these tissues depend on selenium provided by SelP). This selenoprotein is the only mammalian protein that contains multiple Sec residues (31). Previously, we
suggested that the number of Sec residues in SelP might be used
as an indirect genetic marker of selenium utilization (45). In
rodents and primates, the Sec content of SelP is almost twice as
low as in aquatic vertebrates. Comparison of rodent SelPs
shows that C. porcellus and MR SelPs have 7 Sec residues,
which is the lowest number of SelP Sec residues in vertebrates.
MR, porcupine, and C. porcellus are closer to each other and are
more distant from other rodents, such as mice, rats, and rabbits
(46). Our analysis of GPx1 expression suggested a decreased
GPx1 expression in MR and porcupine, and previous research
revealed low GPx1 activity in C. porcellus (47). Overall, these
data suggest a possible loss of GPx1 function in this specific
group of rodents and, as a consequence, a reduced requirement
for selenium by these organisms. It is remarkable that such an
important selenoprotein is compromised in these animals,
which survived for tens of millions of years essentially without
GPx1.
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5. Park, T. J., Lu, Y., Jüttner, R., Smith, E. S., Hu, J., Brand, A., Wetzel, C.,
Milenkovic, N., Erdmann, B., Heppenstall, P. A., Laurito, C. E., Wilson,
S. P., and Lewin, G. R. (2008) PLoS Biol. 6, e13
6. Woodley, R., and Buffenstein, R. (2002) Comp. Biochem. Physiol. A Mol.
Integr. Physiol. 133, 827– 834
7. Larson, J., and Park, T. J. (2009) Neuroreport 20, 1634 –1637
8. Seluanov, A., Hine, C., Azpurua, J., Feigenson, M., Bozzella, M., Mao, Z.,
Catania, K. C., and Gorbunova, V. (2009) Proc. Natl. Acad. Sci. U.S.A. 106,
19352–19357
9. Liang, S., Mele, J., Wu, Y., Buffenstein, R., and Hornsby, P. J. (2010) Aging
Cell 9, 626 – 635
10. Andziak, B., O’Connor, T. P., Qi, W., DeWaal, E. M., Pierce, A., Chaudhuri, A. R., Van Remmen, H., and Buffenstein, R. (2006) Aging Cell 5,
463– 471
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Supplementary Information

Figure S1. Quantification of Se in mouse and MR tissues. Se was quantified in XFM scans of similar
areas of mouse and MR tissues. At least 3 representative XFM images were used for each quantification.
Organs in which trace elements were analyzed are shown below each panel.
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Figure S2. Protein sequence alignment of SelP. The following sequences were used for alignment
construction (Genbank accession numbers): Homo sapiens (AAH58919.1); Canis familiaris
(NP_001108590.1); Sus scrofa (NP_001128295.1); Mus musculus (AAH01991.2); and Rattus norvegicus
(NP_062065.2). Selenocysteine residues are highlighted in red, and cysteines in the positions corresponding
to selenocysteine are shown in blue.
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*
MCAARLAAAAAAAQ---SVYAFSARPLAGGEPVSLGSLRGKVLLIENVASLUGTTVRDYT
MCAAQRSAAALAAVAPRSVYAFSARPLAGGEPISLGSLRGKVLLIENVASLUGTTVRDYT
MCAAALAAAAVAAAP-RSVYAFSARPLAGGEPMSLGSLRGKVLLIENVASLUGTTVRDYT
MCAARLSAAAQSTV-----YAFSARPLTGGEPVSLGSLRGKVLLIENVASLUGTTIRDYT
MSAARLSAVAQSTV-----YAFSARPLAREEPVSLGSLRGKVLLIENVASLUGTTTRDYT
MCAARLVAAAQATV-----YSFSARPLAGGEPLNFGSLRGKVLLIENVASLUGTTVRDFT
MCAGRLAAAAQATV-----YSFSARPLTGGEPLSLGSLRGKVLLIENVASLUGTTVRDFT

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Cavia porcellus
Heterocephalus glaber

1
1
1
1
1
1
1

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Cavia porcellus
Heterocephalus glaber

58
61
59
56
56
55
56

QMNELQRRLGPRGLVVLGFPCNQFGHQENAKNEEILNSLKYVRPGGGFEPNFMLFEKCEV
QMNELQRRLGPRGLVVLGFPCNQFGHQENAKNGEILNCLKYVRPGGGFEPNFMLFEKCEV
QMNELQRRLGPRGLVVLGFPCNQFGHQENAKNEEILNSLKYVRPGGGFEPNFTLFEKCEV
EMNDLQKRLGPRGLVVLGFPCNQFGHQENGKNEEILNSLKYVRPGGGFEPNFTLFEKCEV
EMNDLQKRLGPRGLVVLGFPCNQFGHQENGKNEEILNSLKYVRPGGGFEPNFTLFEKCEV
QMNDLQARLGHKGLVVLGFPCNQFGHQENAKNEEILHSLKYVRPGGGFEPNFTLFEKCEV
QMNQLQARFGPRGLVVLGFPCNQFGHQENAKNEEILHLLKYVRPGGGFEPNFTLFEKCEV

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Cavia porcellus
Heterocephalus glaber

118
121
119
116
116
115
116

NGAGAHPLFAFLREALPAPSDDATALMTDPKLITWSPVCRNDVAWNFEKFLVGPDGVPLR
NGANAHPLFAFLREALPTPSDDATALMTDPKFITWSPVCRNDIAWNFEKFLVGPDGVPLR
NGAQAHPLFAFLRESLPAPSDDTTALMTDPKFITWSPVCRNDVAWNFEKFLVGPDGVPVR
NGEKAHPLFTFLRNALPTPSDDPTALMTDPKYIIWSPVCRNDIAWNFEKFLVGPDGVPVR
NGEKAHPLFTFLRNALPAPSDDPTALMTDPKYIIWSPVSRNDISWNFEKFLVGPDGVPVR
NGAKAHPLFTFLREALPAPSDDPIALMTDPKFIIWSPVCRNDVSWNFEKFLVGPDGVPVR
NGAKAHPLFTFLREALPAPSDEPTALMTDPKFIIWSPVCRNDVAWNFEKFLVGPDGVPVR

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Cavia porcellus
Heterocephalus glaber

178
181
179
176
176
175
176

RYSRRFQTIDIEPDIEALLSQGPSCA
RYSRRFLTIDIEPDIEALLSQEPSSA
RYSRRFPTIDIEPDIEALLSQGPSCA
RYSRRFRTIDIEPDIETLLSQQSGNS
RYTRRFRTIDIEPDIEALLSKQSSNP
RYSRRFPTIDIEPDIEALLSQGSGPA
RYSRRFPTIDIEPDIKALLT&

Figure S3. Protein sequence alignment of GPx1. The following sequences were used for alignment
construction (Genbank accession numbers): Homo sapiens (NP_000572.2); Sus scrofa (NP_999366.1);
Canis familiaris (NP_001108591); Rattus norvegicus (AAB95647.2), Mus musculus (CAA27558) and
Cavia porcellus (AAKN02012894.1). The selenocysteine residue is highlighted in red and indicated by an
asterisk. The early stop codon in the MR sequence is also highlighted in red.
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Homo sapiens
Sus scrofa
Canis familiaris
Oryctolagus cuniculus
Mus musculus
Rattus norvegicus
Heterocephalus glaber

1
1
1
1
1
1
1

*
-----MAFIAKSFYDLSAISLDG-EKVDFNTFRGRAVLIENVASLUGTTTRDFTQLNELQ
-----MAYIAKSFYDLSAISLDG-EKVDFNTFRGRAVLIENVASLUGTTTRDFTQLNELQ
-----MAYIAKSFYDLSAISLDG-EKVDFNTFRGRAVLIENVASLUGTTTRDFTQLNELQ
MCAARMAAAAQSVYSFSAHPLAGGEPVNLGSLRGKVLLIENVASLUGTTVRDYTQMNELQ
-----MAYIAKSFYDLSAVGLDG-EKIDFNTFRGRAVLIENVASLUGTTTRDYNQLNELQ
-----MAYIAKSFYDLSAIGLDG-EKIDFNTFRGRAVLIENVASLUGTTTRDYTQLNELQ
-------------------ALDG-EKVDFNTFRGRVVLIENVASLUGTTTRDFTQLNELQ

Homo sapiens
Sus scrofa
Canis familiaris
Oryctolagus cuniculus
Mus musculus
Rattus norvegicus
Heterocephalus glaber

55
55
55
61
55
55
41

CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGYQPTFTLVQKCEVNGQNEH
CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGFQPTFTLIQKCDVNGQNEH
CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGFQPTFTLVQKCEVNGQNEH
ERLGPRALVVLGFPCNQFGHQENAKNEEILNSLKYVRPGGGFEPNFMLFQKCEVNGAKAS
CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGYQPTFSLTQKCDVNGQNEH
CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGFQPTFSLTQKCDVNGQNQH
CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGSGFQPTFTLVQKCEVNGQNEH

Homo sapiens
Sus scrofa
Canis familiaris
Oryctolagus cuniculus
Mus musculus
Rattus norvegicus
Heterocephalus glaber

114
114
114
121
114
114
100

PVFAYLKDKLPYPYDDPFSLMTDPKLIIWSPVRRSDVAWNFEKFLIGPEGEPFRRYSRTF
PVFAYLKDKLPYPYDDPFSLMTDPKFIIWSPVRRSDVSWNFEKFLIGPEGEPFRRYSRTF
PVFAYLKDKLPYPYDDPLSLMTDPKFIIWSPVRRSDVAWNFEKFLIGPEGEPFRRYSRTF
PLFAFLREALPPPSDDPTALMTDPKFITWCPVCRNDVSWSFEKFLVGPDGVPVRRYSRRF
PVFAYLKDKLPYPYDDPFSLMTDPKLIIWSPVRRSDVSWNFEKFLIGPEGEPFRRYSRSF
PVFAYLKDKLPYPYDDPFSLMTDPKLIIWSPVRRSDVSWNFEKFLIGPEGEPFRRYSRTF
PVFAYLKDKLPYPYDDPFSLMTDPKLIMWSPVRRNDVAWNFEKFLVGPDGVPVRRYSRRF

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Oryctolagus cuniculus
Rattus norvegicus
Heterocephalus glaber

174
174
174
174
181
174
160

PTINIEPDIKRLLKVAI--PTINIEPDIKRLLKVAI--PTINIEPDIKRLLKVAI--QTINIEPDIKRLLKVAI--PTIDIEPDIQALLSKGSGGA
QTINIEPDIKRLLKVAI--PTIDIEPDIKALL-------

Figure S4. Protein sequence alignment of GPx2. The following sequences were used for alignment
construction (Genbank accession numbers): Homo sapiens (NP_002074.2); Sus scrofa (NP_001108608.1);
Canis familiaris (NP_001108607.1); Oryctolagus cuniculus (NP_001078913.1); Rattus norvegicus
(NP_899653.2) and Mus musculus (NP_109602.2). The MR sequence is incomplete. The selenocysteine
residue is highlighted in red and indicated by an asterisk.
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Homo sapiens
Homo sapiens
Mus musculus
Rattus norvegicus
Cavia porcellus
Heterocephalus glaber

1
1
1
1
1
1

MSLGRLCRLLKPALLCGALAAPGLAGTMCASRDDWRCARSMHEFSAKDIDGHMVNLDKYR
MSFSRLFRLLKPTLLCGTLAVPGLAGTMCASRDDWRCARSMHEFSAKDIDGHMVNLDKYR
MSWGRLSRLLKPALLCGALAAPGLAGTMCASRDDWRCARSMHEFSAKDIDGHMVCLDKYR
MSWGRLSRLLKPALLCGALAVPGLAGTMCASRDDWRCARSMHEFSAKDIDGHMVCLDKYR
---------------------------MCASRDDWRCARSMHEFATKDIDGHMVCLDKYR
----RLSRLLKPALLCGALTAPGLAGTMCASRDDWRSAHSMHEFSAKDIDGHMVSLDKYK

Homo sapiens
Sus scrofa
Mus musculus
Rattus norvegicus
Cavia porcellus
Heterocephalus glaber

61
61
61
61
34
57

*
GFVCIVTNVASQUGKTEVNYTQLVDLHARYAECGLRILAFPCNQFGKQEPGSNEEIKEFA
GYVCIVTNVASQUGKTEVNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSDAEIKEFA
GFVCIVTNVASQUGKTDVNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSNQEIKEFA
GCVCIVTNVASQUGKTDVNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSNQEIKEFA
GCVCIVTNVASQUGKTDVNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSNQEIKEFA
GFVCIVTNVASQUGKTEVNYTQFVDLHARYAECGLCILAFPCNQFGKQEPGTNEEVKHFA

Homo sapiens
Sus scrofa
Mus musculus
Rattus norvegicus
Cavia porcellus
Heterocephalus glaber

121
121
121
121
94
117

AGYNVKFDMFSKICVNGDDAHPLWKWMKIQPKGKGILGNAIKWNFTKFLIDKNGCVVKRY
AGYNVKFDMFSKICVNGDDAHPLWKWMKVQPKGRGMLGNAIKWNFTKFLIDKNGCVVKRY
AGYNVKFDMYSKICVNGDDAHPLWKWMKVQPKGRGMLGNAIKWNFTKFLIDKNGCVVKRY
AGYNVRFDMYSKICVNGDDAHPLWKWMKVQPKGRGMLGNAIKWNFTKFLIDKNGCVVKRY
AGYNVRFDMYSKICVNGDDAHPLWKWMKVQPKGRGMLGNAIKWNFTKFLIDKNGCVVKRY
AGYNVKFDMFSKICVNGDDAHPLWKWMKVQPKGKGMLGNAIKWNFTKFLIDKNGCVVKRY

Homo sapiens
Sus scrofa
Mus musculus
Rattus norvegicus
Cavia porcellus
Heterocephalus glaber

181
181
181
181
154
177

GPMEEPLVIEKDLPHYF
GPMEEPQVIEKDLPCYL
GPMEEPQVIEKDLPCYL
GPMEEPQVIEKDLPCYL
GPMEEPQVIEKDLPCYL
GPMEEPLVIEKDLTCYL

Figure S5. Protein sequence alignment of GPx4. The following sequences were used for alignment
construction (Genbank accession numbers): Homo sapiens (NP_002076.2); Sus scrofa (NP_999572.1);
Mus musculus (NP_032188.3); Rattus norvegicus (AAC52503.2); and Cavia porcellus (BAA92142.1). MR
and C. porcellus sequences are incomplete. The selenocysteine residue is highlighted in red and indicated
by an asterisk.
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1
1
1
1
1
1

Homo_sapiens
Sus_scrofa
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus glaber

61
61
61
61
61
61

*
MALAVRVVYCGAUGYKSKYLQLKKKLEDEFPGRLDICGEGTPQATGFFEVMVAGKLIHSK
MGVAVRVVYCGAUGYKSKYLQLKKKLEDEFPGRLDICGEGTPQVTGFFEVLVAGKLVHSK
MALAVRVVYCGAUGYKSKYLQLKKKLEDEFPGCLDICGEGTPQATGFFEVTVAGKLVHSK
MALAVRVVYCGAUGYKPKYLQLKEKLEHEFPGCLDICGEGTPQVTGFFEVTVAGKLVHSK
MALAVRVVYCGAUGYKPKYLQLKEKLEHEFPGCLDICGEGTPQVTGFFEVTVAGKLVHSK
MALSVRVVYCGAUGYKPKYLQLKEKLEDEFPGCLDICGEGTPQSTGFFEVTIAGKLVHSK

Homo_sapiens
Sus_scrofa
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus glaber

KKGDGYVDTESKFLKLVAAIKAALAQGKGGDGYVDTESKFLKLVAAIKAALAQGKRGDGYVDTESKFLRLVAAIKTALAQGKRGDGYVDTESKFRKLVTAIKAALAQCQ
KRGDGYVDTESKFRKLVTAIKAALAQCQ
KGGDGFVDTNSKFRKLVAAIKAALAQG-

Figure S6. Protein sequence alignment of SelW. The following sequences were used for alignment
construction (Genbank accession numbers): Homo sapiens (NP_003000.1); Sus scrofa (NP_999142.1);
Canis familiaris (NP_001108484.1); Mus musculus (NP_033182.1); and Rattus norvegicus (NP_037159.3).
The selenocysteine residue is highlighted in red and indicated by an asterisk.

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

1
1
1
1
1
1

*
MAPRGRKRKAEAAVVAVAEKREKLANGGEGMEEATVVIEHCTSURVYGRNAAALSQALRL
MASRGRKRKAETALGAAAEKQETPASGRKGMEEASVVIEHCTSURVYGRNAAALSQALRL
MASRGRKRKAEAAGVAAAEKREKPASGRKAVEEATVVIEHCTSURVYGRNAAALSQALRL
MAPHGRKRKAGAAPMETVDKREKLAEG------ATVVIEHCTSURVYGRHAAALSQALQL
MAPLGRKRKAGAAPIESADKREKLAEG------AAVVIEHCTSURVYGRHAAALSQALQL
MAPRGRKRKAEASEVGSAGKREELADSGAGAAEVQVVIEHCTSURVYARQAAALSQALRE

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

61
61
61
55
55
61

EAPELPVKVNPTKPRRGSFEVTLLRPDGSSAELWTGIKKGPPRKLKFPEPQEVVEELKKY
EAPELPVRVNPTKPRRGSFEVTLMRPDGSSAELWTGIKKGPPRKLKFPEPQEVVEELKKY
ETPELPVEVNPAKPRRGSFEVTLLRPDGSSVELWTGIKKGPPRKLKFPEPQEVVKALKQH
EAPELPVQVNPSKPRRGSFEVTLLRSDNSRVELWTGIKKGPPRKLKFPEPQEVVEELKKY
EAPEISVQVNRSKPRRGSFEVTLLRPDNSRVELWTGIKKGPPRKLKFPEPQEMVEELKKY
AAPQLAVALNPARPRRGSFEVTLRRADGSSAPLWTGIKKGPPRKLKFPEPQAVVEELSKH

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

121
121
121
115
115
121

LS
LS
LS
LS
LS
LP

Figure S7. Protein sequence alignment of SelH. The following sequences were used for alignment
construction (Genbank accession numbers): Homo sapiens (NP_734467.1); Sus scrofa (NP_001171877.1);
Mus musculus (NP_001028338.1); Rattus norvegicus (NP_001108411.1); and Canis familiaris
(NP_001157978.1). The selenocysteine residue is highlighted in red and indicated by an asterisk.
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Homo_sapiens
Sus_scrofa
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber

1
1
1
1
1
1

MAAGPSGCLVPAFGLRLLLATVLQAVSAFGAEFSSEACRELGFSSNLLCSSCDLLGQFNL
MAAEPGGWLGPALGLRLLLATALQMVSAFGAEFSSESCRELGFSSNLLCGSCDLLGQFDL
MAPGPGGRLGPALRLRLLLAAVLQAVSTFGAEFSSEACRELGFSSNLLCSSCDLLGQFNL
MAAGQGGWLRPALGLRLLLATAFQAVSALGAEFASEACRELGFSSNLLCSSCDLLGQFNL
MAAGQGGWLRPALGLRLLLATAFQAVSALGAEFSSEACRELGFSSNLLCSSCDLLGQFNL
MAAGSGAWFGPAFGLRLLLASVLHAVSAFKAEFSSEACTELGFSSNLLCSSCDLLGQFNL

Homo_sapiens
Sus_scrofa
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber

61
61
61
61
61
61

*
LQLDPDCRGCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY
LQLDPDCRGCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY
LQLDPDCRRCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY
LPLDPVCRGCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY
LPLDPVCRGCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY
LQLDPDCRGCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY

Homo_sapiens
Sus_scrofa
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber

121
121
121
121
121
121

VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLERI
VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLQRV
VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLERI
VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLERI
VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLERI
VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLERI

Figure S8. Protein sequence alignment of the 15 kDa selenoprotein. The following sequences were used
for alignment construction (Genbank accession numbers): Homo sapiens (NP_004252.2); Sus scrofa
(NP_001078912.1); Rattus norvegicus (NP_579831.2); Mus musculus (Q9ERR7.3); and Canis familiaris
(NP_001108232.1). The selenocysteine residue is highlighted in red and indicated by an asterisk.
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Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

1
1
1
1
1
1

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

61
61
61
61
61
61

MSFCSFFGGEVFQNHFEPGVYVCAKCGYELFSSRSKYAHSSPWPAFTETIHADSVAKRPE
MSFCSFFGGEVFQNHFEPGVYVCAKCGYELFSSHSKYAHSSPWPAFTETIHADSVAKRPE
MSFCSFFGGEVFQNHFEPGVYVCAKCGHELFSSRSKYAHSSPWPAFTETIHADSVAKRPE
MSFCSFFGGEVFQNHFEPGVYVCAKCSYELFSSHSKYAHSSPWPAFTETIHADSVTKCPE
MSFCSFFGGEVFQNHFEPGVYVCAKCGYELFSSRSKYAHSSPWPAFTETIHEDSVAKCPE
MSFCSFFGGEVFQNHFEPGIYVCAKCGYELFSSRSKYAHSSPWPAFTDAIHTDSVAKCQE
*
HNRSEALKVSCGKCGNGLGHEFLNDGPKPGQSRFUIFSSSLKFVPKGKETSASQGH
HNRPGALKVSCGRCGNGLGHEFLNDGPKRGQSRFUIFSSSLKFIPKGQESSPSQGQ
RNSPEALKVSCGKCGNGLGHEFLNDGPKPGKSRFUIFSSSLKFIPKGKGTSGSQEA
KNRPEALKVSCGKCGNGLGHEFLNDGPKRGQSRFUIFSSSLKFVPKGKEAAASQGH
KNRPEALKVSCGKCGNGLGHEFLNDGPKRGQSRFUIFSSSLKFIPKGKEAPASQGD
RNRPGALKVSCGRCGNGLGHEFLNDGPKQGQSRFUIFSSSLKFIPKDKETSASQGH

Figure S9. Protein sequence alignment of MsrB1. The following sequences were used for alignment
construction (Genbank accession numbers): Homo sapiens (NP_057416.1); Sus scrofa (NP_001090929.1);
Canis familiaris (NP_001108221.1); Mus musculus (AAI41147.1); and Rattus norvegicus
(NP_001037750.2). The selenocysteine residue is highlighted in red and indicated by an asterisk.
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Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

1
1
1
1
1
1

*
MRLLLLLLVAASAMVRSEASANLGGVPSKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR
MRLLLLFLVAASAVVRSDASANMGGVPGKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR
MRYLLVLLVAASAVIRSDASANLGGVPSKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR
MRLLLLLLVAASAVVRSEASANLGGVPSKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR
MRLLLLLLVAASAVVRSEASANLGGVPSKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR
--------MAASAVVRSEASGNLGGVPSKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

61
61
61
61
61
53

VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW
VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW
VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW
VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW
VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW
VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

121
121
121
121
121
113

GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE
GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE
GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE
GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE
GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE
GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

181
181
181
181
181
173

MKLNVHMDSIPHHRS
MKLNVHMDSIPHHRS
MKLNVHMDSIPHHRS
MKLNVHMDSIPHHRS
MKLNVHMDSIPHHRS
MKLNVHMDSIPHHRS

Figure S10. Protein sequence alignment of SelT. The following sequences were used for alignment
construction (Genbank accession numbers): Homo sapiens (NP_057359.2); Sus scrofa (NP_001156880.1);
Canis familiaris (NP_001157959.1); Mus musculus (NP_001035486.2); and Rattus norvegicus
(NP_001014275.2). The selenocysteine residue is highlighted in red and indicated by an asterisk.
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Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Chinchilla lanigera
Heterocephalus glaber

1
1
1
1
1
1
1

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Chinchilla lanigera
Heterocephalus glaber

61
61
61
61
61
61
61

MVYISNGQVLDSRSQSPWRLSLITDFFWGIAEFVVLFFKTLLQQDVKKRRSYGNSSDSRY
MVYISNGQALDSRSQSPWRLSFITDFFWGIAEFVVLFFRTLLQQDVKKRRGYGGSSDSRY
MVYISNGQVLDSRSQSPWRLSLITDFFWGIAEFVVLFFKTLLQQDVKKRRGYGNSSDSRY
MVYISNGQVLDSRNQSPWRVSFLTDFFWGIAEFVVFFFKTLLQQDVKKRRGYGSSSDSRY
MVYISNGQVLDSRNQSPWRLSFITDFFWGIAEFVVFFFKTLLQQDVKKRRGYGGSSDSRY
MVYISNGQVLDSRSQSPWRLSLITDFFWGIAEFVVLFFKTLLQQDVKKGRGYRNSSDSRY
MVYISNGQVLDSRSQSPWRLSLITDFFWGIAEFVVLFFKTLLQQDVKKGRGYRNSSDSRY
*
DDGRGPPGNPPRRMGRINHLRGPSPPPMAGGUGR
DDGRGPPGNPPRRMGRINHLRGPNPPPMAGGUGR
DDGRGPPGNPPRRMGRINHLRGPSPPPMAGGUGR
DDGRGPPGNPPRRMGRISHLRGPSPPPMAGGUGR
DDGRGPPGNPPRRMGRISHLRGPSPPPMAGGUGR
DDGRGPPGNPPRRMGRISHLHGPSPPPMAGGUGR
DDGRGPPGNPPRRMGRINHLQGPSPPPMGGGUGR

Figure S11. Protein sequence alignment of SelK. The following sequences were used for alignment
construction (Genbank accession numbers): Homo sapiens (NP_067060.2); Sus scrofa (NP_001038018.2);
Canis familiaris (NP_001108350.1); Mus musculus (NP_064363.2); Rattus norvegicus (NP_997472.2); and
Chinchilla lanigera (AAR26540.1). The selenocysteine residue is highlighted in red and indicated by an
asterisk.
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Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

1
1
1
1
1
1

MERQEESLSARPALETEGLRFLHTTVGSLLATYGWYIVFSCILLYVVFQKLSARLRALRQ
MEQDGDQLSARPALETEGLRFLHVTVGSLLATYGWYIVFCCILLYVVFQKLSTRLRALRQ
MERDGQQLSARPALETEGLRYLHVTVGSLLATYGWYIVFSCILLYVVFQKLSTRLRALRQ
MDRDEEPLSARPALETESLRFLHVTVGSLLASYGWYILFSCILLYIVIQRLSLRLRALRQ
MDRGEEPLSARPALETESLRFLHVTVGSLLASYGWYILFSCVLLYIVIQKLSLRLRALRQ
-----ELLSARPALETEGLRFLHVTVGSLLATYGWYILFSCILLY---------------

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

61
61
61
61
61
41

RQLDRAAAAVEPDVVVKRQEALAAARLKMQEELNAQVEKHKEKLKQLEEEKRRQKIEMWD
RHLDGAAAALEPDVVVKRQEALAAARLKMQEELNAQVEKHKEKLRQLEEEKRRQKIERWD
RQLDRAEAAVEPDVVVKRQEALAAARLKMQEELNAQVEKHKEKLRQLEEQKRRQKIEMWD
RQLDQAETVLEPDVVVKRQEALAAARLRMQEDLNAQVEKHKEKLRQLEEEKRRQKIEMWD
RQLDQAEAVLEPDVVVKRQEALAAARLRMQEDLNAQVEKHKEKLRQLEEEKRRQKIEMWD
---------------------------------NAQVEKHKEKLRQLEEEKRRQKIEMWD

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

121
121
121
121
121
68

SMQEGKSYKGNAKKPQEEDSPGPSTSSVL-KRKSDRKPLRGGGYNPLSGEGGGACSWRPG
SVQEGRSYRGDARKRQEEDSPGPSTSSVIPKRKSDKKPLRGGGYNPLSGEGGGACSWRPG
SMQEGKSYKGNARKHPEEDSPGPSTSSVLPKRKPDRKPLRGGGYNPLSGEGGGACSWRPG
SMQEGRSYKRNSGRPQEEDGPGPSTSSVIPKGKSDKKPLRGGGYNPLTGEGGGTCSWRPG
SMQEGRSYKRNSGRPQEEDGPGPSTSSVIPKGKSDKKPLRGGGYNPLTGEGGGTCSWRPG
SMQEGKSYKRNARKPQE-DSPGPSTSSTIPKRKSDKKPLRGSGYNPLTGEGGGACSWRPG

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

180
181
181
181
181
127

*
RRGPSSGGUG
RRGPSSGGUG
RRGPSSGGUG
RRGPSSGGUN
RRGPSSGGUS
RRGPSSGGUG

Figure S12. Protein sequence alignment of SelS. The following sequences were used for alignment
construction (Genbank accession numbers): Canis familiaris (NP_001108229.1); Homo sapiens
(NP_060915.2); Mus musculus (NP_077759.3); Rattus norvegicus (NP_775143.2); and Sus scrofa
(NP_001157585.1). The MR sequence is incomplete. The selenocysteine residue is highlighted in red and
indicated by an asterisk.
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Homo_sapiens
Sus_scrofa
Canis_familiaris
Oryctolagus_cuniculus
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber

1
1
1
1
1
1
1

MGLPQPGLWLKRLWVLLEVAVHVVVGKVLLILFPDRVKRNILAMGEKTGMTRNPHFSHDN
MELPLPGLWLKRLWVLFQVALHVAMGKVLMTLFPGRVKQDILAMSQKTGMAKNPHFSHEN
MGLPRPVLWLRRLWVLLQVAVQVAVGKVFLKLFPARVKQHIVAMNGK-----NPHFSYDN
MGLPRPGLWLKRLWVLVQVAVEVAVGKVLMTLFPERVKQNILAMGQKTGIAQNPNFAQDS
MGLPQLWLWLKRLVIFLQVALEVAVGKVLMTLFPGRVKQSILAMGQKTGMARNPRFAPDN
MGLSQLWLWLKRLVIFLQVALEVATGKVLMTLFPERVKQNILAMGQKTGMTRNPRFAPDN
MGLPRPGLWLKRLWVLVQVTVEVAMGKVLMTLFPDRIKKNILAMGQKTGMTRNPQFSHDN

Homo_sapiens
Sus_scrofa
Canis_familiaris
Oryctolagus_cuniculus
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber

61
61
56
61
61
61
61

WIPTFFSTQYFWFVLKVRWQRLEDTTELGGLAPNCPVVRLSGQRCNIWEFMQGNRPLVLN
WIPTFFSAQYFWFVLKVRWQRLEDKTEEGGLAPNCPVVSLSGQRCHIWDFMQGNRPLVLN
WAPTLYSMQYFWFVLKVQWQRLEDRTEPGGLAPNCPVVRLSGQRCNIWDFMQGNRPLVLN
WIPTFFSTQYFWFVLKVRWQRLEDATEPGGLAPNCSVVRLSGQQCSVWDFMRGNRPLVLN
WVPTFFSIQYFWFVLKVRWQRLEDRAEFGGLAPNCTVVCLSGQKCNIWDFIQGSRPLVLN
WVPTFFSIQYFWFVLKVRWQRLEDRAEYGGLAPNCTVVRLSGQKCNVWDFIQGSRPLVLN
WIPTFFSTQYFWFILKVRWQRLEDTAELGGLAPDCSVVCLSGQKCTIWDFMQGNRPLVLN

Homo_sapiens
Sus_scrofa
Canis_familiaris
Oryctolagus_cuniculus
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber

121
121
116
121
121
121
121

*
FGSCTUPSFMFKFDQFKRLIEDFSSIADFLVIYIEEAHASDGWAFKNNMDIRNHQNLQDR
FGSCTUPSFIFKFDQFKRLIEDFSSIADFLIIYIEEAHASDGWAFKNNVDIKNHQNLQDR
FGSCTUPSFLFKFDQFKRLIEDFCSTADFLIIYIEEAHASDGWAFKNNVNIRTHQTLQDR
FGSCTUPSFLSKFDQFKRLIQDFSSIADFLIIYIEEAHASDGWAFKNNVDIKNHRNLQDR
FGSCTUPSFLLKFDQFKRLVDDFASTADFLIIYIEEAHATDGWAFKNNVDIRQHRSLQER
FGSCTUPSFLLKFDQFKRLVDDFASTADFLIIYIEEAHATDGWAFKNNVDIRQHRSLQDR
FGSCTUPSFMFKFDQFKRLIEDFHLIADFLIIYIEEAHASDGWAFKNNMDIRQHRNLQDR

Homo_sapiens
Sus_scrofa
Canis_familiaris
Oryctolagus_cuniculus
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber

181
181
176
181
181
181
181

LQAAHLLLARSPQCPVVVDTMQNQSSQLYAALPERLYIIQEGRILYKGKSGPWNYNPEEV
LRAAHLLLDRSPQCPVVVDTMKNQSSRLYAALPERLYVLQAGRILYKGKPGPWNYHPEEV
LQAARLLLDRAPPCPVVVDTMRNQSSQFYAALPERLFVLQEGRILYKGKPGPWNYHPEEV
LRAASLLLARSPQCPVVVDTMQNQSSQLYAALPERLYVLRQGRILYKGESGPWNYNPEEV
VRAARLLLARSPQCPVVVDTMQNQSSQLYAALPERLYVIQEGRICYKGKAGPWNYNPEEV
LRAAHLLLARSPQCPVVVDTMQNQSSQLYAALPERLYVIQEGRICYKGKPGPWNYNPEEV
MRAAHLLLTKTPQCPVVVDTMQNQSSQLYAALPERLYVLQEGRILYKGKSGPWNYNPEEV

Homo_sapiens
Sus_scrofa
Canis_familiaris
Oryctolagus_cuniculus
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber

241
241
236
241
241
241
241

RAVLEKLHS-------RAVLEKLHS-------RAVLEKLHS-------RAVLEELHS-------RAVLEKLCTPPRHVPQL
RAVLEKLCIPPGHMPQF
HAVLEKLRSQPGQIPLL

Figure S13. Protein sequence alignment of DI1. The following sequences were used for alignment
construction (Genbank accession numbers): Oryctolagus cuniculus (NP_001093428.1); Homo sapiens
(NP_000783.2); Sus scrofa (NP_001001627.1); Mus musculus (Q61153.3); Rattus norvegicus
(NP_067685.5); and Canis familiaris (NP_001007127.1). The selenocysteine residue is highlighted in red
and indicated by an asterisk.
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Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

1
1
1
1
1
1

*
MSLLLPPLALLLLLAALVAPATAATAYRPDWNRLSGLTRARVETCGGUQLNRLKEVKAFV
MHLPPLSLPLLLLLAALAA---ATTTFRPDWNRLQGLARARVETCGGUQLNRLKEVKAFV
MRLPLPPPPLLLLLAALAA---AVTTFRPDWNRLHGLARARVETCGGUQLNRLKEVKAFV
MSILLSPPSLLLLLAALVAPATSTTNYRPDWNRLRGLARGRVETCGGUQLNRLKEVKAFV
MNILLSPPPLLLLLAALVAPATSITTYRPDWNRLRGLARGRVETCGGUQLNRLKEVKAFV
-------------------------------------------TCGGUQLNRLKEVKAFV

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

61
58
58
61
61
18

TQDIPFYHNLVMKHLPGADPELVLLGRRYEELERIPLSEMTREEINALVQELGFYRKAAP
TQDIPLYHNLVMKHLPGADPELVLLGHRFEELERIPLSDMTREEINALVQELGFYRKAAP
TQDIPLYHNLVMKHLPGADPELVLLGHHYEELERIPLSEMTREEINELVQELGFYRKAAP
TEDIQLYHNLVMKHLPGADPELVLLSRNYQELERIPLSQMTRDEINALVQELGFYRKSAP
TQDIQLYHNLVMKHLPGADPELVLLSRNYQELERIPLSQMTRDEINALVQELGFYRKSAP
TEDIPLYHNLVMKHLPGADPELVLLNNLYEELERIPLSPMTREEINALVQELGFYRKVAR

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

121
118
118
121
121
78

DAQVPPEYVWAPAKPPEETSDHADL
EDPVPPEYMRAPARPAEGAPDRADL
DEAVPPEYLRAPARPAEGAPDRADL
EAQVPPEYLWAPAKPPEEASEHDDL
EAKVPPEYLWAPAKPPEDASDRADL
DAQVPPEYLWAPAKAP---------

Figure S14. Protein sequence alignment of SelM. The following sequences were used for alignment
construction (Genbank accession numbers): Homo sapiens (NP_536355.1); Mus musculus (NP_444497.1);
Rattus norvegicus (NP_001108485.1); Canis familiaris (NP_001108486.1); and Sus scrofa
(NP_001155120.1). The MR sequence is incomplete. The selenocysteine residue is highlighted in red and
indicated by an asterisk.
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Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

1
1
1
1
1
1

MAEASATGACGEAMAAAEG---SSGPAGLTLGRSFSNYRPFEPQALGLSPSWRLTGFSGM
MAEAAATGAGGEMMAAVAAGEGCSGPAGLSLGRGFSGYRPFEPQALGLSPSWRLTGFSGM
MAEAAATGAGGEVAAAAEG----SGSAGLSLGRGFSSYRPFEPQALGLSPSWRLTGFSGM
MAEAAAAGASGETMAALVAAEGSLGPAGWSAGRSFSNYRPFEPQTLGFSPSWRLTSFSGM
MAEAAAG-ASGEAMAALVAAEGSLGPAGWSAGRSFSNYRPFEPQTLGFSPSWRLTSFSGM
---------------------------------------PFEPQALGLSPSWRLTGFSGM

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

58
61
57
61
60
22

*
KGUGCKVPQEALLKLLAGLTRPDVRPPLGRGLVGGQEEASQEAGLPAGAGPSPTFPALGI
KGUGCKVPQETLLKLLAGLTRPEVRPPVGRGLVGGLEEAAQEAGLPVRAEPSPTFPTLGI
KGUGCKVPQETLLKLLAGLTRPEVRPPLGLGLVGSHEEAAQEGGLPAGADPNPTFPALGI
KGUGCKVPQETLLKLLEGLTRPALQPPLTSGLVGGQEETVQEGGLSTRPGPGSAFPSLSI
KGUGCKVPQETLLKLLEGLTRPALQPPLTSGLVGGQEETVQEGGLTTRPGPGSAFPSLSI
KGUGCKVPQEALLKLLAGLTRP--------------------------------------

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

118
121
117
121
120
44

GMDSCVIPLRHGGLSLVQTTDFFYPLVEDPYMMGRIACANVLSDLYAMGITECDNMLMLL
GLDSCVIPLRHGGLSLVQTTDFFYPLVEDPYMMGRIACANVLSDLYAMGITECDNMLMLL
GMDSCVIPLRHGGLSLVQTTDFFYPLVEDPYMMGRIACANVLSDLYAMGITECDNMLMLL
GMDSCVIPLRHGGLSLVQTTDFFYPLVEDPYMMGRIACANVLSDLYAMGITECDNMLMLL
GMDSCVIPLRHGGLSLVQTTDFFYPLVEDPYMMGRIACANVLSDLYAMGITECDNMLMLL
-------------------------------MMGRIACANVLSDLYAMGITECDNMLMLL

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

178
181
177
181
180
73

SVSQSMSEEEREKVTPLMVKGFRDAAEEGGTAVTGGQTVVNPWIIIGGVATVVCQPNEFI
SVSQNMIEEEREKITPLMIKGFRDAAEEGGTAVTGGQTVINPWIIIGGVATVVCQPNEFI
SVSQSMTEEEREKITPLMIKGFRDAAEEGGTAVTGGQTVVNPWIIVGGVATVVCQPNEFI
SVSQSMSEKEREKVTPLMIKGFRDAAEEGGTAVTGGQTVVNPWIIIGGVATVVCQQNEFI
SVSQSMSEKEREKVTPLMIKGFRDAAEEGGTAVTGGQTVVNPWIIIGGVATVVCQQNEFI
SVSQNMNEEEREKVTPLMIKGFRDAAEEGGTAVTGGQTVVNPWIIIGGVATVVCQPNEFI

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

238
241
237
241
240
133

MPDSAVVGDVLVLTKPLGTQVAVNAHQWLDNPERWNKVKMVVSREEVELAYQEAMFNMAT
MPDSAVVGDVLVLTKPLGTQVAVNAHQWLDNPERWNKIKMVVSREEVELAYQEAMFNMAT
MPDSAVVGDVLVLTKPLGTQVAVNAHQWLDNPERWNKINMVVSREEVELAYQEAMFNMAT
MPDSAVVGDVLVLTKPLGTQVAANAHQWLDNPEKWNKIKMVVSREEVELAYQEAMFNMAT
MPDSAVVGDVLVLTKPLGTQVAANAHQWLDNPEKWNKIKMVVSREEVELAYQEAMFNMAT
MPDSAVVGDVLVLTKPLGTQVAVNAHQWLDNPERWDKINMVVSREEVELAYQEAMFNMAT

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

298
301
297
301
300
193

LNRTAAGLMHTFNAHAATDITGFGILGHSQNLAKQQRNEVSFVIHNLPIIAKMAAVSKAS
LNRTAAGLMHTFNAHAATDITGFGILGHSQNLAKQQRNEVSFVIHNLPIIAKMAAISKAS
LNRTAAGLMHTFNAHAATDITGFGILGHSQNLAKQQRNEVSFVIHNLPIIAKMAAISKAS
LNRTAAGLMHTFNAHAATDITGFGILGHSQNLAKQQKNEVSFVIHNLPIIAKMAAISKAS
LNRTAASLMHTFNAHAATDITGFGILGHSQNLAKQQKNEVSFVIHNLPIIAKMAAISKAS
LNRTAAGLMHTFNAHAATDITGFGILGHSQNLAKQQRNEVSFVIHNLPIIAKMAAISKAS

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

358
361
357
361
360
253

GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII
GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII
GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII
GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII
GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII
GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII

Homo sapiens
Sus scrofa
Canis familiaris
Mus musculus
Rattus norvegicus
Heterocephalus glaber

418
421
417
421
420
313

DKPRVIEVLPRGATA--AVLAPDSSNASSEPSS
DKPRVIEVLPRGTAA--TALAPENSSASSEPSL
DKPRVIEVLPRGATA--TALAPDNSNASSEPSS
DKPRVIEVLPRGASAA-AAAAPDNSNAASEPSS
DKPRVIEVLPRGASAS-AAAAPDNSNAASEPSS
DKPRVIEVLPRGAAAPALALAADNSSASSERTL

Figure S15. Protein sequence alignment of SPS2. The following sequences were used for alignment
construction (Genbank accession numbers): Canis familiaris (NP_001108208.1); Homo sapiens
(NP_036380.2); Sus scrofa (NP_001087204.1); Rattus norvegicus (NP_001073358.2); and Mus musculus
14

(NP_033292.2). The naked mole rat sequence is incomplete. The selenocysteine residue is highlighted in
red and indicated by an asterisk.
Sus_scrofa
Oryctolagus_cuniculus
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber
Homo_sapiens

1
1
1
1
1
1
1

-----MAALRGPAGLFRWRLRVVPGGARG-------AAGQQCYDLLVIGGGSGGLACAKE
--------MR--------------------------VAGQPTYDLLVIGGGSGGLACAKE
---MSSCGIRAPALTWPFLSPLS-------------AAGQQNYDLLVIGGGSGGLACAKE
MVAAMVAALRGPSRRFRPRTRALTRGTR---GAASAAGGQQSFDLLVIGGGSGGLACAKE
-MAAIVAALRGSSGRFRPQTRVLTRGTRGAAGAASAAGGQQNFDLLVIGGGSGGLACAKE
------------------------------------------------------------MAAMAVALRGLGGRFRWRTQAVAGGVRG--AARGAAAGQRDYDLLVVGGGSGGLACAKE

Sus_scrofa
Oryctolagus_cuniculus
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber
Homo_sapiens

49
27
45
58
60
1
58

AAQLGKKVAVVDYVSPSPRGTRWGLGGTCVNVGCIPKKLMHQAALLGGVIRDAPHYGWEV
AAQLGRKVAVLDYVEPSPRGTRWGLGGTCVNVGCIPKKLMHQAALLGGAIRDAGRYGWEV
AAQLGKKVAVVDYVEPSPRGTKWGLGGTCVNVGCIPKKLMHQAALLGSMIRDAPHYGWDV
AAQLGKKVAVADYVEPSPRGTKWGLGGTCVNVGCIPKKLMHQAALLGGMIRDAHHYGWEV
AAQLGRKVAVADYVEPSPRGTKWGLGGTCVNVGCIPKKLMHQAALLGGMIRDAQHYGWEV
-----------------------------------------------------------AAQLGRKVAVVDYVEPSPQGTRWGLGGTCVNVGCIPKKLMHQAALLGGLIQDAPNYGWEV

Sus_scrofa
Oryctolagus_cuniculus
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber
Homo_sapiens

109
87
105
118
120
1
118

VQPALHSWRKMAEAVQNHVKSLNWGHRVQLQDRKVKYFNFKASFVNKHTVCGVSKGGKEI
AQPARHDWSKMAEAIQNHVRSLNWGHRVQLQERKVKYLNVKARFIDKHTVLGVSKDKKET
AQPVLHDWRTMAEAVQNHVKSLNWGHRVQLQDRKVTYFNVKASFVNEHTVCGVAKGGKET
AQPVQHNWKTMAEAVQNHVKSLNWGHRVQLQDRKVKYFNIKASFVDEHTVRGVDKGGKAT
AQPVQHNWKAMAEAVQNHVKSLNWGHRVQLQDRKVKYFNIKASFVNEHTVHGVDKAGKVT
---------KMAEAVQNHVKSLNWGHRVQ----------IKASFVNKYTVCGITKGGKEM
AQPVPHDWRKMAEAVQNHVKSLNWGHRVQLQDRKVKYFNIKASFVDEHTVCGVAKGGKEI

Sus_scrofa
Oryctolagus_cuniculus
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber
Homo_sapiens

169
147
165
178
180
42
178

LLSAEHIVIATGGRPRYPAHIEGAVEYGITSDDIFWLKESPGKTLVVGASYVALECAGFL
LLSADHIVIATGGRPRYPTLIQGASEYGITSDDIFWLKESPGKTLVVGASYVALECAGFL
LLSAEHIVIATGGRPRYPTHIEGALEYGITSDDIFWLKESPGKTLVVGASYVALECAGFL
LLSAEHIVIATGGRPRYPTQVKGALEYGITSDDIFWLKESPGKTLVVGASYVALECAGFL
QLSAKHIVIATGGRPKYPTQVKGALEHGITSDDIFWLKESPGKTLVVGASYVALECAGFL
LLSAEHIVIATGGRPKYPTHIEGALEYGITSDDIFWLKESPGKTLVVGASYIALECAGFL
LLSADHIIIATGGRPRYPTHIEGALEYGITSDDIFWLKESPGKTLVVGASYVALECAGFL

Sus_scrofa
Oryctolagus_cuniculus
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber
Homo_sapiens

229
207
225
238
240
102
238

TGLGLDATIMIRSIPLRAFDQQMASLVIEHMAVHGTRILKGCMPLRVEKLPDGQLQVTWV
TGLGLDTTIMIRSIPLRGFDQQMASLVTDHMASHGTRILRGCTPSRVARLPDGRLQVTWE
TGLGLDTTIMIRSIPLRGFDQQMSSLVTEYMASQGTRFLRGCTPSRVRRLPDGQLQVTWE
TGIGLDTTVMMRSIPLRGFDQQMSSLVTEHMESHGTQFLKGCVPSHIKKLPTNQLQVTWE
TGIGLDTTVMMRSVPLRGFDQQMASLVTEHMESHGTRFLKGCVPSLIRKLPTNQLQVTWE
TGIGLDTTVMMRSIPLRGFDQQMSSLVTEHMESHGTRFLRGCTPSHIRKLPDGQLQVTWK
TGIGLDTTIMMRSIPLRGFDQQMSSMVIEHMASHGTRFLRGCAPSRVRRLPDGQLQVTWE

Sus_scrofa
Oryctolagus_cuniculus
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber
Homo_sapiens

289
267
285
298
300
162
298

DLASDRKDVGTFDTVLWATGRVPEIGSLNLEKAGVHTNPHTQKILVDAQDATSVPHIYAI
DRTCGKEDSGVFNTVLWAIGRVPETRGLNLEGAGVETNPESQKILVDARDTTSVPHIYAI
NLTSGKEDVGTFDTVLWAIGRIPETKSLNLEKAGVNTNPNSQKILVNAQEATSIPHIYAI
DHASGKEDTGTFDTVLWAIGRVPETRTLNLEKAGISTNPKNQKIIVDAQEATSVPHIYAI
DLASGKEDVGTFDTVLWAIGRVPETRNLNLEKAGVNTNPKNQKIIVDAQEATSVPHIYAI
DGISGKEDTGTFDTVLWAIGRVPETRSLNLEKAGVNTNSQNQKIFVDSQEATSVPHIYAI
DSTTGKEDTGTFDTVLWAIGRVPDTRSLNLEKAGVDTSPDTQKILVDSREATSVPHIYAI

Sus_scrofa
Oryctolagus_cuniculus
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber
Homo_sapiens

349
327
345
358
360
222
358

GDVAEGRPELTPTAVMAGRLLAQRLCGRSSDLMDYDNVPTTVFTPLEYGCVGLSEEAAVA
GDVAEGRPELTPTAIMAGKLLAQRLFGGSSDLMDYSNVPTTVFTPLEYGCVGLSEEEAVA
GDVAEGRPELTPTAIMAGRLLAQRLCGQASDVMDYDNVPTTVFTPLEYGCVGLSEEEAVT
GDVAEGRPELTPTAIKAGKLLAQRLFGKSSTLMDYSNVPTTVFTPLEYGCVGLSEEEAVA
GDVAEGRPELTPTAIKAGKLLAQRLFGKSSTLMNYSNVPTTVFTPLEYGCVGLSEEEAVA
GDVAEGRPELTPTAIMAG------------------------------ACVGLSEEEAVA
GDVVEGRPELTPTAIMAGRLLVQRLFGGSSDLMDYDNVPTTVFTPLEYGCVGLSEEEAVA

Sus_scrofa
Oryctolagus_cuniculus
Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber
Homo_sapiens

409
387
405
418
420
252
418

RHGEEGVEVYHAYYKPLEFTVPERDASQCYIKMVCLREPPQLVRGLHFLGPNAGEVTQGF
RHGQEQIEVYHAYYKPLEFTVAEQDASQCYIKMVCLRQPPQPVLGLHFLGPNAGEVTQGF
RHGEEHVEVYHAYYKPLEFTVAERDASQCYVKMVCLRKPPQLVLGLHFLGPNAGEVTQGF
LHGQEHVEVYHAYYKPLEFTVADRDASQCYIKMVCMREPPQLVLGLHFLGPNAGEVTQGF
LHGQEHIEVYHAYYKPLEFTVADRDASQCYIKMVCMREPPQLVLGLHFLGPNAGEVTQGF
RHGQEHVEVYHAYYKPLEFTVAERDASQCYIKMVCLREPPQLVLGLHFLGPNAGEVTQGF
RHGQEHVEVYHAHYKPLEFTVAGRDASQCYVKMVCLREPPQLVLGLHFLGPNAGEVTQGF

Sus_scrofa
Oryctolagus_cuniculus

*
469 ALALKCGASYEQVMRTVGIHPTCAEEVAKLRISKRSGLDPTVTGCUG
447 ALGIKCGASYEQVIRTVGIHPTCAEEMVKLRISKRSGLDPTVTGCUG
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Canis_familiaris
Mus_musculus
Rattus_norvegicus
Heterocephalus_glaber
Homo_sapiens

465
478
480
312
478

ALGIKCGASYAQVMRTVGIHPTCAEEVAKLRITKRSGLDPTVTGCUG
ALGIKCGASYAQVMQTVGIHPTCSEEVVKLHISKRSGLEPTVTGCUG
ALGIQCGASYAQVMQTVGIHPTCSEEVVKLHISKRSGLDPTVTGCUG
TLGIKCGASYAQVMRTVGIHPTCAEEVVKLRISKRSGLDPTVTGCUG
ALGIKCGASYAQVMRTVGIHPTCSEEVVKLRISKRSGLDPTVTGCUG

Figure S16. Protein sequence alignment of mitochondrial thioredoxin reductase. The following
sequences were used for alignment construction (Genbank accession numbers): Homo sapiens
(BAA77601.2); Canis familiaris (XP_850181.1); Mus musculus (Q9JLT4.4); Rattus norvegicus
(NP_072106.1); Sus scrofa (NP_001162173.1); and Oryctolagus cuniculus (XP_002722800.1). The MR
sequence is incomplete. The selenocysteine residue is highlighted in red and indicated by an asterisk.
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Figure S17. Expression of mouse and MR GPx1 in E. coli. Cysteine mutants of MR and mouse GPx1
were cloned into pET28a and expressed in E. coli. (A) Proteins were isolated from identical amounts of
bacterial culture and aliquots were analyzed by SDS-PAGE. (B) Glutathione peroxidase activity of MR and
mouse GPx1 was measured and normalized to the amount of protein in each sample. Results are given +/SD.
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Figure S18. Expression of GPx1 in skin fibroblasts of rodents and long lived mammals. (A) Cells were labeled
with 75Se followed by SDS-PAGE and autoradiography. HEK 293 cells and MEFs derived from GPx1 KO mice were
used as positive and negative controls, respectively. Migration of the band corresponding to GPx1 is shown with an
arrow. (B) Schematic representation of the phylogenetic tree of rodents (adapted from (46)).
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